Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
850 USD | +1.52% | +3.61% | +45.82% |
12:00pm | Added health benefits of Wegovy, Zepbound could attract more men, doctors say | RE |
11:07am | Eli Lilly: promising trial for tirzepatide in MASH | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.54% | 248B | |
-2.00% | 219B | |
+10.80% | 216B | |
+5.90% | 164B | |
-0.73% | 162B | |
-0.28% | 123B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Deutsche Bank Adjusts Price Target on Eli Lilly to $725 From $695